Starpharma Investor Presentation Petalion Webinar

Oct 20, 2026 at 11:53 PM EDT · Issued by Starpharma Holdings Limited via ASX

Filed with ASX · Oct 20, 2026 at 11:53 PM EDT · 17 pages · English

On 6ix: 6ix.com/news/starpharma-investor-presentation-petalion-webinar

Release

ASX Announcement Starpharma Investor Presentation – Petalion Webinar Melbourne, Australia; 21 October 2026: Starpharma (ASX: SPL, US OTC: SPHRY), an innovative biotechnology company advancing dendrimer technology from the lab to the patient, provides the investor presentation delivered at...

Starpharma Holdings Limited on 6ix

In the deck

Starpharma Holdings — Investor Presentation (October 2026)17 slidesOct 21, 2026

Earlier from Starpharma

Starpharma secures majority ownership of PetalionOct 19
Trading HaltOct 15
Change in substantial holdingOct 7
Notice of Annual General Meeting/Proxy FormOct 5
Change of Director's Interest Notice - C MaleyOct 4

Later from Starpharma

$3.5 Million R&D Tax Incentive ReceivedOct 21
Quarterly Activities/Appendix 4C Cash Flow ReportOct 21
Details of Company AddressOct 23
Application for quotation of securities - SPLOct 29
Becoming a substantial holderNov 2

All Starpharma news releases

Follow Starpharma into a list and get an email when it puts out news.

Follow Starpharma